BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11708771)

  • 21. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter.
    Gorrill TS; Khalili K
    Virology; 2005 Apr; 335(1):1-9. PubMed ID: 15823601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.
    Chinenov Y; Kerppola TK
    Oncogene; 2001 Apr; 20(19):2438-52. PubMed ID: 11402339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor.
    Bierhaus A; Zhang Y; Deng Y; Mackman N; Quehenberger P; Haase M; Luther T; Müller M; Böhrer H; Greten J
    J Biol Chem; 1995 Nov; 270(44):26419-32. PubMed ID: 7592857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transcription factor AP-1 binds to the human interleukin 1 alpha promoter.
    Bailly S; Fay M; Israël N; Gougerot-Pocidalo MA
    Eur Cytokine Netw; 1996; 7(2):125-8. PubMed ID: 8688489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A.
    Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H
    Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B.
    Gobin SJ; Keijsers V; van Zutphen M; van den Elsen PJ
    J Immunol; 1998 Sep; 161(5):2276-83. PubMed ID: 9725221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of TNF-alpha-sensitive sites in HCMVie1 promoter.
    Zhang H; Fu S; Busch A; Chen F; Qin L; Bromberg JS
    Exp Mol Pathol; 2001 Oct; 71(2):106-14. PubMed ID: 11599916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biphasic control of NF-kappa B activation induced by the triggering of HLA-DR antigens expressed on B cells.
    Leonardi A; Altomonte M; Maio M; Tell G; Bearz A; Formisano S; Pucillo C
    Cytokine; 1997 May; 9(5):295-9. PubMed ID: 9195127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation.
    DelaTorre A; Schroeder RA; Kuo PC
    Biochem Biophys Res Commun; 1997 Sep; 238(3):703-6. PubMed ID: 9325152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells.
    Chen YJ; Chang LS
    Biochim Biophys Acta; 2015 Oct; 1849(10):1248-59. PubMed ID: 26260845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding.
    delaTorre A; Schroeder RA; Bartlett ST; Kuo PC
    Surgery; 1998 Aug; 124(2):137-41; discussion 141-2. PubMed ID: 9706131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANKing c-Jun in osteoclast development.
    Teitelbaum SL
    J Clin Invest; 2004 Aug; 114(4):463-5. PubMed ID: 15314680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells.
    Zhou LZ; Johnson AP; Rando TA
    Free Radic Biol Med; 2001 Dec; 31(11):1405-16. PubMed ID: 11728812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection and characterization of an RNA decoy for transcription factor NF-kappa B.
    Lebruska LL; Maher LJ
    Biochemistry; 1999 Mar; 38(10):3168-74. PubMed ID: 10074372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities.
    Min W; Ghosh S; Lengyel P
    Mol Cell Biol; 1996 Jan; 16(1):359-68. PubMed ID: 8524315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor.
    Schjerven H; Tran TN; Brandtzaeg P; Johansen FE
    J Immunol; 2004 Aug; 173(3):1849-57. PubMed ID: 15265917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.
    Stein B; Baldwin AS; Ballard DW; Greene WC; Angel P; Herrlich P
    EMBO J; 1993 Oct; 12(10):3879-91. PubMed ID: 8404856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65.
    Handel ML; McMorrow LB; Gravallese EM
    Arthritis Rheum; 1995 Dec; 38(12):1762-70. PubMed ID: 8849348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Formation of recognition site in transcription factors: repressor of phage lambda and a murine immunoglobulin factor].
    Chirgadze IuN; Larionova EA
    Mol Biol (Mosk); 2001; 35(5):836-43. PubMed ID: 11605537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.